ASXC Asensus Surgical Dashboard

TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

Company profile

Ticker

ASXC, TRXC, TRXDW

Exchange

NYSE

Website

www.transenterix.com/

CEO

Anthony Fernando

Incorporated

Delaware

Location

North Carolina

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

Former names

CELLULAR TECHNICAL SERVICES CO INC, SafeStitch Medical, Inc., TRANSENTERIX INC., TRANSENTERIX, INC.

SEC CIK

0000876378

Corporate docs

Articles of Incorporation & Bylaws

IRS number

112962080

ASXC stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

55 Biggest Movers From Yesterday

13 Apr 21

Gainers

42 Stocks Moving In Monday's Mid-Day Session

12 Apr 21

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake of 18.4% in the company on Friday.

44 Biggest Movers From Yesterday

9 Apr 21

Gainers Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 111.5% to close at $55.00 on Thursday.

TransEnterix, Inc. Common Stock Q4 EPS $(0.09) Up From $(0.83) YoY, Sales $1.11M Up From $688.00K YoY

11 Mar 21

Earnings Scheduled For March 11, 2021

11 Mar 21

Press releases

Pro users get this 30m faster

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2020

11 Mar 21

Asensus Surgical, Inc. (NYSE:ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating

TransEnterix, Inc. to Host Earnings Call

11 Mar 21

NEW YORK, NY / ACCESSWIRE / March 11, 2021 / TransEnterix, Inc. (NYSE:ASXC) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 11, 2021 at 4:30 PM Eastern Time.To

Asensus Surgical Announces Finalization of Name and Ticker Symbol Change

5 Mar 21

Effective on March 5, 2021, Asensus Surgical will trade under ticker symbol ASXC Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE:ASXC), a medical device company that is digitizing the interface between the

Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

4 Mar 21

Asensus Surgical Announces FDA Clearance in General Surgery

3 Mar 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

11 Mar 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart ASXC financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	17.53M	17.53M	17.53M	17.53M	17.53M	17.53M
Cash burn (monthly)	1.2M	(positive/no burn)	4.64M	5.08M	4.26M	3.89M
Cash used (since last report)	4.13M	n/a	16.03M	17.54M	14.7M	13.44M
Cash remaining	13.4M	n/a	1.5M	-6.12K	2.83M	4.09M
Runway (months of cash)	11.2	n/a	0.3	-0.0	0.7	1.1

Beta Read what these cash burn values mean

Recent insider trades

ASXC insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
31 Mar 21	David Bruce Milne	Common Stock	Grant	Aquire A	No	No	0	3,792	0	211,098
31 Mar 21	Pfenniger Richard C JR	Common Stock	Grant	Aquire A	No	No	0	4,242	0	80,474
31 Mar 21	Starling William N JR	Stock Option Common Stock	Grant	Aquire A	No	No	3.25	3,628	11.79K	3,628
31 Mar 21	Hsiao Jane PH D	Stock Option Common Stock	Grant	Aquire A	No	No	3.25	3,155	10.25K	3,155
31 Mar 21	Biffi Andrea	Stock Option Common Stock	Grant	Aquire A	No	No	3.25	3,155	10.25K	3,155

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

ASXC institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

8.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	67	65	+3.1%
Opened positions	12	11	+9.1%
Closed positions	10	15	-33.3%
Increased positions	15	10	+50.0%
Reduced positions	10	13	-23.1%

13F shares	Current	Prev Q	Change
Total value	12.55M	2.62M	+378.9%
Total shares	20.08M	7.56M	+165.7%
Total puts	144.23K	119.73K	+20.5%
Total calls	902.6K	1.29M	-30.0%
Total put/call ratio	0.2	0.1	+72.2%

Largest owners	Shares	Value	Change
Empery Asset Management	6.45M	$4.03M	NEW
Sabby Management	4.99M	$3.12M	NEW
Vanguard	2.16M	$1.35M	+18.3%
Renaissance Technologies	1.43M	$892K	-26.2%
Masters Capital Management	900K	$562K	0.0%
Kepos Capital	681.16K	$426K	+70.3%
BLK Blackrock	603.91K	$377K	-32.3%
Millennium Management	415.22K	$260K	NEW
Geode Capital Management	364.29K	$227K	+239.9%
DB Deutsche Bank AG - Registered Shares	288.6K	$180K	0.0%

Largest transactions	Shares	Bought/sold	Change
Empery Asset Management	6.45M	+6.45M	NEW
Sabby Management	4.99M	+4.99M	NEW
Renaissance Technologies	1.43M	-505.46K	-26.2%
Millennium Management	415.22K	+415.22K	NEW
Vanguard	2.16M	+333.29K	+18.3%
BLK Blackrock	603.91K	-287.84K	-32.3%
Kepos Capital	681.16K	+281.16K	+70.3%
Geode Capital Management	364.29K	+257.12K	+239.9%
Honkamp Krueger Financial Services	201.96K	+201.96K	NEW
Susquehanna International	179.59K	+149.92K	+505.3%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Medtronic • Titan Medical • Intuitive Surgical • Medtronic • Memic Innovative Surgery

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accessibility, AdventHealth, age, ago, Aid, aim, Alexander, alliance, Amsterdam, Appendix, ASXC, Baptist, bariatric, benchmark, billion, bolstered, broader, call, calling, Canada, Canadian, captured, celebrate, Celebration, Centre, cessation, chain, Chairman, chart, chronic, Commonwealth, compensatory, complicated, composed, constantly, constrained, constraining, consumption, Continental, contributor, creative, culture, database, David, decade, deep, DEI, distancing, economy, employ, encourage, encouraged, enriched, envision, era, ethnicity, Exhibit, expert, female, filer, forgiven, formatted, foundation, foundational, frailty, gastrectomy, gender, goal, guaranty, guide, halted, harbor, heard, height, herewith, hiatal, holistically, home, Hsaio, ideal, inducement, Inline, insignificant, interaction, Jane, Jr, kicked, Kingdom, landlord, largest, LaViolette, Linkbase, lived, logical, lookback, Louisiana, LSU, Maastricht, Memic, mental, Milne, mission, neurodiversity, Nicholson, NOL, nominal, Ochsner, omitted, onsite, optimize, orientation, page, paraesophageal, passed, passionate, Paul, Paycheck, payroll, People, Pfenniger, pioneer, Pittsburgh, plaguing, poor, PPE, PPP, proctoring, progression, prompted, proportionate, race, Rampertab, ratifying, recommence, refocused, regained, regular, religion, remote, remotely, resonate, resubstitution, resurgence, Richard, Roszdravnadzor, Russia, Russian, Saitama, SBA, Schema, seamlessly, setup, sexual, Shameze, shocking, signatory, similarly, size, sized, skill, sleeve, society, sought, southeast, Southern, Specimen, standby, Starling, stead, strive, stronger, succeed, SurgeryTM, talent, tapping, Taxonomy, tenant, thereunto, therewith, thing, thrive, ticker, tied, timeline, top, Trust, TW, unadopted, undersigned, underwent, unissued, University, unlock, unlocking, unprecedented, unsatisfied, unsecured, urgency, valorem, vast, virtue, vital, webpage, William, XBRL

Removed: achieved, added, Advancement, advantage, affecting, appeal, assuming, bankruptcy, clarify, Codification, combining, comparative, contact, contracting, convey, criterion, CSIMC, decreasing, deductible, Deferral, Distinguishing, embedded, entrance, existed, expended, foregoing, forma, gaining, incurrence, indefinite, indeterminate, indexed, Institute, intermediate, landscape, magnitude, Mandatorily, MINE, monetary, Morrisville, movement, nationwide, negotiation, Noncontrolling, Nonpublic, notice, objective, organization, Orlando, owe, pattern, PIPE, posture, preclude, principally, procedural, Pte, purport, receiving, Redeemable, reduction, refinancing, remeasured, repay, resale, revaluation, revalue, round, royalty, schedule, separability, spending, Stifel, strike, substantive, Synchrony, Synecor, thereon, unamortized, unaudited, unqualified

From filing 10-K 2020 FY